Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05586139Not ApplicableNot Yet Recruiting

Microbiome-Directed Food for Sustained Recovery From Acute Malnutrition

Role: collaborator

NCT04582474Not ApplicableUnknown

Demonstration of an Electronic Clinical Decision Support Module for Dengue in Burkina Faso

Role: collaborator

NCT02199951Unknown

Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania

Role: collaborator

NCT01115647Not ApplicableCompleted

Treating Moderate Malnutrition in 6-24 Months Old Children

Role: collaborator

All 4 trials loaded